Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank20
3Y CAGR-33.7%
5Y CAGR+40.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-33.7%/yr
Annual compound
5Y CAGR
+40.3%/yr
Recent deceleration
Percentile
P20
Within normal range
vs 5Y Ago
5.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $35.63M | -46.7% |
| 2023 | $66.89M | -48.6% |
| 2022 | $130.10M | +6.5% |
| 2021 | $122.16M | +179.1% |
| 2020 | $43.78M | +568.1% |
| 2019 | $6.55M | - |